Free Trial
→ The Altcoin That Could be Poised to Benefit Most from Trump’s Return (From Weiss Ratings) (Ad) Free BTX Stock Alerts

Brooklyn ImmunoTherapeutics (BTX) SEC Filings & 10K Form

Brooklyn ImmunoTherapeutics logo
$7.31 -0.01 (-0.14%)
As of 08/1/2025 03:59 PM Eastern

Recent Brooklyn ImmunoTherapeutics SEC Filings

Export to Excel
DateFilerForm TypeView
07/07/2025
7:00 PM		Ernexa Therapeutics Inc. (Issuer)
Ernexa Therapeutics Inc. (Issuer)
Brooklyn ImmunoTherapeutics (Issuer)
Gurrola Sandra M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/19/2025
11:15 PM		Ernexa Therapeutics Inc. (Filer)
Ernexa Therapeutics Inc. (Filer)
Brooklyn ImmunoTherapeutics (Filer)
Form EFFECT
06/11/2025
7:34 PM		Cherington Charles (Reporting)
Ernexa Therapeutics Inc. (Issuer)
Ernexa Therapeutics Inc. (Issuer)
Brooklyn ImmunoTherapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2025
7:39 PM		Cherington Charles (Filed by)
Ernexa Therapeutics Inc. (Subject)
Ernexa Therapeutics Inc. (Subject)
Brooklyn ImmunoTherapeutics (Subject)
Form SCHEDULE 13D/A
06/11/2025
3:30 PM		Ernexa Therapeutics Inc. (Filer)
Ernexa Therapeutics Inc. (Filer)
Brooklyn ImmunoTherapeutics (Filer)
Form S-3
Registration statement under Securities Act of 1933  
06/11/2025
3:35 PM		Ernexa Therapeutics Inc. (Filer)
Ernexa Therapeutics Inc. (Filer)
Brooklyn ImmunoTherapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
05/15/2025
8:13 PM		Ernexa Therapeutics Inc. (Subject)
Ernexa Therapeutics Inc. (Subject)
Brooklyn ImmunoTherapeutics (Subject)
HALPERN JOHN D (Filed by)
Form SCHEDULE 13G/A
05/15/2025
3:42 PM		Ernexa Therapeutics Inc. (Subject)
Ernexa Therapeutics Inc. (Subject)
Brooklyn ImmunoTherapeutics (Subject)
Konar Shameek (Filed by)
Form SCHEDULE 13G
05/14/2025
7:39 PM		Ernexa Therapeutics Inc. (Subject)
Ernexa Therapeutics Inc. (Subject)
Brooklyn ImmunoTherapeutics (Subject)
IAF, LLC (Filed by)
Form SCHEDULE 13G/A
05/14/2025
1:14 PM		Ernexa Therapeutics Inc. (Subject)
Ernexa Therapeutics Inc. (Subject)
Brooklyn ImmunoTherapeutics (Subject)
Freebird Partners LP (Filed by)
Form SCHEDULE 13G/A
05/07/2025
10:48 AM		Cherington Charles (Reporting)
Ernexa Therapeutics Inc. (Issuer)
Ernexa Therapeutics Inc. (Issuer)
Brooklyn ImmunoTherapeutics (Issuer)
Form 4/A
04/29/2025
11:15 PM		Ernexa Therapeutics Inc. (Filer)
Ernexa Therapeutics Inc. (Filer)
Brooklyn ImmunoTherapeutics (Filer)
Form EFFECT
04/16/2025
3:30 PM		Ernexa Therapeutics Inc. (Filer)
Ernexa Therapeutics Inc. (Filer)
Brooklyn ImmunoTherapeutics (Filer)
Form S-3
Registration statement under Securities Act of 1933  
04/14/2025
4:05 PM		Ernexa Therapeutics Inc. (Filer)
Ernexa Therapeutics Inc. (Filer)
Brooklyn ImmunoTherapeutics (Filer)
Form ARS
04/04/2025
9:54 AM		Cherington Charles (Reporting)
Eterna Therapeutics Inc. (Issuer)
Eterna Therapeutics Inc. (Issuer)
Brooklyn ImmunoTherapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/04/2025
9:55 AM		Cherington Charles (Filed by)
Eterna Therapeutics Inc. (Subject)
Eterna Therapeutics Inc. (Subject)
Brooklyn ImmunoTherapeutics (Subject)
Form SCHEDULE 13D/A
04/03/2025
4:17 PM		Eterna Therapeutics Inc. (Filer)
Eterna Therapeutics Inc. (Filer)
Brooklyn ImmunoTherapeutics (Filer)
Form PRE 14A
04/03/2025
7:55 AM		Eterna Therapeutics Inc. (Filer)
Eterna Therapeutics Inc. (Filer)
Brooklyn ImmunoTherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/26/2025
6:30 AM		Eterna Therapeutics Inc. (Filer)
Eterna Therapeutics Inc. (Filer)
Brooklyn ImmunoTherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/24/2025
3:30 PM		Eterna Therapeutics Inc. (Filer)
Eterna Therapeutics Inc. (Filer)
Brooklyn ImmunoTherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/12/2025
3:15 PM		Eterna Therapeutics Inc. (Filer)
Eterna Therapeutics Inc. (Filer)
Brooklyn ImmunoTherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/12/2025
3:20 PM		Eterna Therapeutics Inc. (Filer)
Eterna Therapeutics Inc. (Filer)
Brooklyn ImmunoTherapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/05/2025
4:55 PM		Cherington Charles (Filed by)
Eterna Therapeutics Inc. (Subject)
Eterna Therapeutics Inc. (Subject)
Brooklyn ImmunoTherapeutics (Subject)
Form SCHEDULE 13D/A
02/14/2025
8:30 PM		Eterna Therapeutics Inc. (Subject)
Eterna Therapeutics Inc. (Subject)
Brooklyn ImmunoTherapeutics (Subject)
Singer Nicholas Jason (Filed by)
Form SCHEDULE 13G/A
02/14/2025
7:36 PM		Eterna Therapeutics Inc. (Subject)
Eterna Therapeutics Inc. (Subject)
Brooklyn ImmunoTherapeutics (Subject)
HALPERN JOHN D (Filed by)
Form SCHEDULE 13G/A
02/12/2025
4:54 PM		Eterna Therapeutics Inc. (Subject)
Eterna Therapeutics Inc. (Subject)
Brooklyn ImmunoTherapeutics (Subject)
IAF, LLC (Filed by)
Form SCHEDULE 13G/A
02/10/2025
6:00 PM		Eterna Therapeutics Inc. (Issuer)
Eterna Therapeutics Inc. (Issuer)
Brooklyn ImmunoTherapeutics (Issuer)
Luther Sanjeev (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/10/2025
6:00 PM		Cicala Peter (Reporting)
Eterna Therapeutics Inc. (Issuer)
Eterna Therapeutics Inc. (Issuer)
Brooklyn ImmunoTherapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/10/2025
6:00 PM		Bristol James Arthur (Reporting)
Eterna Therapeutics Inc. (Issuer)
Eterna Therapeutics Inc. (Issuer)
Brooklyn ImmunoTherapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/10/2025
6:00 PM		Eterna Therapeutics Inc. (Issuer)
Eterna Therapeutics Inc. (Issuer)
Brooklyn ImmunoTherapeutics (Issuer)
Gurrola Sandra M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/10/2025
6:00 PM		Eterna Therapeutics Inc. (Issuer)
Eterna Therapeutics Inc. (Issuer)
Brooklyn ImmunoTherapeutics (Issuer)
Wexler William A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/28/2025
4:31 PM		Eterna Therapeutics Inc. (Subject)
Eterna Therapeutics Inc. (Subject)
Brooklyn ImmunoTherapeutics (Subject)
Freebird Partners LP (Filed by)
Form SCHEDULE 13G/A
01/14/2025
4:00 PM		Eterna Therapeutics Inc. (Issuer)
Eterna Therapeutics Inc. (Issuer)
Brooklyn ImmunoTherapeutics (Issuer)
Ratner Elena (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
01/14/2025
4:01 PM		Eterna Therapeutics Inc. (Issuer)
Eterna Therapeutics Inc. (Issuer)
Brooklyn ImmunoTherapeutics (Issuer)
Ratner Elena (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/18/2024
3:15 PM		Eterna Therapeutics Inc. (Filer)
Eterna Therapeutics Inc. (Filer)
Brooklyn ImmunoTherapeutics (Filer)
Form 424B3
11/18/2024
3:15 PM		Eterna Therapeutics Inc. (Filer)
Eterna Therapeutics Inc. (Filer)
Brooklyn ImmunoTherapeutics (Filer)
Form 424B3
11/18/2024
3:15 PM		Eterna Therapeutics Inc. (Filer)
Eterna Therapeutics Inc. (Filer)
Brooklyn ImmunoTherapeutics (Filer)
Form 424B3
11/17/2024
11:15 PM		Eterna Therapeutics Inc. (Filer)
Eterna Therapeutics Inc. (Filer)
Brooklyn ImmunoTherapeutics (Filer)
Form EFFECT
11/14/2024
5:45 AM		Eterna Therapeutics Inc. (Filer)
Eterna Therapeutics Inc. (Filer)
Brooklyn ImmunoTherapeutics (Filer)
Form D
Notice of Exempt Offering of Securities 
11/14/2024
5:45 AM		Eterna Therapeutics Inc. (Filer)
Eterna Therapeutics Inc. (Filer)
Brooklyn ImmunoTherapeutics (Filer)
Form D
Notice of Exempt Offering of Securities 
11/05/2024
3:30 PM		Eterna Therapeutics Inc. (Filer)
Eterna Therapeutics Inc. (Filer)
Brooklyn ImmunoTherapeutics (Filer)
Form S-1
Registration statement under Securities Act of 1933  
The Altcoin That Could be Poised to Benefit Most from Trump’s Return (Ad)

With Trump back in office, the crypto tide is turning fast. Regulation is easing. Momentum is building. And according to Weiss Ratings analyst Juan Villaverde, a major shift is coming. Juan has nailed every major Bitcoin move since 2012—but right now, he says the biggest upside isn’t in BTC or ETH. It’s in a lesser-known altcoin he believes could become the “third pillar of crypto”… and potentially define America’s first true crypto presidency.

See why Washington insiders are quietly buying this coin before it goes public.
11/05/2024
11:42 AM		Cherington Charles (Reporting)
Eterna Therapeutics Inc. (Issuer)
Eterna Therapeutics Inc. (Issuer)
Brooklyn ImmunoTherapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/29/2024
3:30 PM		Eterna Therapeutics Inc. (Filer)
Eterna Therapeutics Inc. (Filer)
Brooklyn ImmunoTherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/16/2024
3:15 PM		Eterna Therapeutics Inc. (Filer)
Eterna Therapeutics Inc. (Filer)
Brooklyn ImmunoTherapeutics (Filer)
Form ARS
09/27/2024
3:47 PM		Eterna Therapeutics Inc. (Filer)
Eterna Therapeutics Inc. (Filer)
Brooklyn ImmunoTherapeutics (Filer)
Form PRE 14A
09/27/2024
3:15 PM		Eterna Therapeutics Inc. (Filer)
Eterna Therapeutics Inc. (Filer)
Brooklyn ImmunoTherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/25/2024
3:36 PM		Eterna Therapeutics Inc. (Filer)
Eterna Therapeutics Inc. (Filer)
Brooklyn ImmunoTherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/23/2024
3:30 PM		Eterna Therapeutics Inc. (Filer)
Eterna Therapeutics Inc. (Filer)
Brooklyn ImmunoTherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/19/2024
4:00 PM		Eterna Therapeutics Inc. (Filer)
Eterna Therapeutics Inc. (Filer)
Brooklyn ImmunoTherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/13/2024
3:30 PM		Eterna Therapeutics Inc. (Filer)
Eterna Therapeutics Inc. (Filer)
Brooklyn ImmunoTherapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools

SEC Filings Tools

This page (NYSE:BTX) was last updated on 8/4/2025 by MarketBeat.com Staff
From Our Partners
Think you missed gold’s boom? Think again
If you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...
Investors Alley | Sponsored
[Shocking New Report] U.S. Dollar To Crash?
The "Death Spiral" Threatening Your Savings But this time, it's not just Dalio ringing the alarm bells…
Goldco Precious Metals | Sponsored
Amazon’s big Bitcoin embarrassment
Bitcoin just passed Amazon in total market cap — but most investors are missing the bigger opportunity. Whi...
Brownstone Research | Sponsored
[Warning] Buffett Indicator hits new All-Time-High
Warren Buffett has leaned on one key indicator for decades—and it just hit an all-time high. That’s not bullis...
Golden Portfolio | Sponsored
Market Crash Warning: How to Protect Your Wealth Before August 12th
China tariffs hit August 12—and experts warn a market meltdown may follow. A free guide from American Alter...
American Alternative | Sponsored
Trump’s crypto advisor may have revealed the next big crypto opportunity
While investors chase Bitcoin toward $100K, D.C. insiders are quietly loading up on something else. One of Tru...
Weiss Ratings | Sponsored
China just unlocked Nvidia’s AI chips—what that means for you
Tired of Missing Big AI Moves Like Nvidia? You’re not the problem—your trading system is. Tim’s XGPT system...
Timothy Sykes | Sponsored
Why AMZN, GOOG, MSFT might destroy NVDA
Investing Legend Hints the End May be Near for These 3 Iconic Stocks Futurist Eric Fry say Amazon, Tesla an...
InvestorPlace | Sponsored